FDA Staff Travels on Drug Industry Dollars
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
“Medication-Free Research in Early Episode Schizophrenia: Evidence of Long-Term Harm?” An article in the Schizophrenia Bulletin, by Dr. John Bola that dares to question the validity of the unexamined treatment paradigm in schizophrenia:
A report by the Drug Abuse Warning Network (DAWN), reveals some sobering facts about teenage suicide attempts that involve drugs.
Unless Congress acts to overrule the FDA, research disasters such as occurred in London, when six healthy men were exposed to an experimental substance that brought them close to death, are likely to occur with increased frequency.
The focus of a recent FDA’s Psychopharmacology Advisory Committee meeting, was the drug, modafinil (as Sparlon), for ADHD and the risk of
Steven-Johnson’s, a rare but potentially fatal, skin condition.
"That thing I’m worried about…where the MedGuide would help, where it might even warrant a black box, if this is common, where somebody hallucinates and then gets put on an anti-psychotic drug. That would really be something worth making sure it doesn’t happen,"
A series of news reports may be a rude awakening to the fact that there are hidden, potentially lethal hazards of participating in clinical trials—and those hazards are concealed from the human guinea pigs who are enticed with promise of easy money.
The pharmaceutical industry’s dilemma: there are few volunteers in the drug-consuming prosperous countries–so they have taken half their business to underdeveloped countries.
On Wednesday, the FDA Pediatric Advisory Committee handed the agency a mixed message regarding warnings about selective list of
psychotropic drugs prescribed for treating ADHD symptoms.
Below a press release from the lawfirm, Baum Hedlund, announces it has filed a class action lawsuit against GlaxoSmithKline charging the company with fraud, negligence, strict liability, and breach of warranty in its marketing of Paxil (Seroxat) by concealing the risk of suicide.
AHRP Urges Actions to Minimize Risks for Children prescribed psychotropic drugs: Action is needed to protect children from widespread prescribing of psychoactive drugs for ill-defined behavioral symptoms.
All six healthy volunteers near death from catastrophic experiment–TGN1412.